The use of PET in the staging of patients with NSCLC is cost-effective, mainly due to a
reduction in the number of futile operations. The addition of SUVmax to pathologic tumor …

Lung cancer is one of the most frequently occurring cancers in the world. Accurate staging of
patients with non-small cell lung cancer (NSCLC) is of paramount importance. It will guide …

This study proposes a new method to reduce respiratory motion artifacts in PET images of
lung cancer. The method is referred to as respiratory-correlated dynamic PET (RCDPET) …

Objective To evaluate the usefulness of a breath-holding (BH) 18 F-2-fluoro-2-deoxy-D-
glucose positron emission tomography (18 F-FDG-PET) technique for PET/computed …

Non–small cell lung cancer (NSCLC) accounts for approximately 80% of bronchogenic
malignancies. The choice of therapy options, including surgery, radiation therapy, and …

Positron emission tomography (PET) is an important imaging modality for personalizing
clinical management of patients with lung cancer. In this regard, PET imaging is essential for …

Positron emission tomography (PET) has shown an increase in both sensitivity and
specificity over computed tomography (CT) in lung cancer. However, motion artifacts in the …

We have reported in our previous studies on the methodology, and feasibility of 4D‐PET
(Gated PET) acquisition, to reduce respiratory motion artifact in PET imaging of the thorax. In …

Lung cancer is a common disease and is a leading cause of death in many countries. The
management of lung cancer is directed by an optimal staging of the tumour. Integrated …

Integrated PET/CT is a new anatomo-metabolic imaging modality combining two different
techniques: Computed Tomography (CT) that provides very detailed anatomic information …